secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001193125-23-200617
Event type: litigation
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos and Janssen reach agreement in principle to settle legal disputes
------------------------------------------------------------------------

- Stipulation to stay case filed July 31, 2023.
- Agreement in principle reached to resolve ongoing disputes with Janssen Biopharma.
- Parties expect to finalize settlement promptly; no financial terms disclosed.
- Litigation previously involved undisclosed claims; resolution removes legal overhang.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523200617/0001193125-23-200617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523200617/d538755d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-200617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer